Tag Archives: LabCorp

March 28, 2024—Labcorp and Opko Health announced they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of Opko, for $237.5 million.

June 2023—Proteomedix (Schlieren, Switzerland) announced an exclusive license agreement in which Labcorp will develop and commercialize its Proclarix prostate specific antigen test in the United States. Proclarix is performed using the same blood sample as a PSA test and is designed to help determine the risk of clinically significant prostate cancer for men who have an elevated total PSA and a digital rectal examination finding that indicates elevated prostate volume but who are not suspected of having cancer.  

March 20, 2023—Enzo Biochem announced it has entered into an agreement in which Labcorp will acquire the assets of its clinical laboratory division, Enzo Clinical Labs.

July 2021—Labcorp and OmniSeq announced the launch of OmniSeq Insight, a pan-cancer, solid tumor test that combines genomic and immune profiling, including tumor mutational burden, microsatellite instability, and immune gene expression, and integrates next-generation sequencing technology.

June 10, 2021—Labcorp and OmniSeq announced the launch of OmniSeq Insight, a next-generation–sequencing, pan-cancer, solid tumor test that combines genomic and immune profiling, including tumor mutational burden, microsatellite instability, and immune gene expression.

January 2021—The FDA authorized the first COVID-19 direct-to-consumer test system­—LabCorp’s Pixel COVID-19 Test Home Collection Kit, for use by any person 18 years and older without a prescription.

Dec. 10, 2020—The FDA authorized the first COVID-19 direct-to-consumer test system­—LabCorp’s Pixel COVID-19 Test Home Collection Kit, for use by any person 18 years and older without a prescription.

December 2019—Sysmex America and LabCorp announced an extension of their hematology automation agreement, to provide LabCorp Diagnostics’ primary reference laboratories with Sysmex America’s latest, upgraded XN-Series technology; the XN-9100 is a scalable, modular automation system that incorporates sample sorting robotics from Yaskawa Motoman.  

Aug. 2, 2019—South Bend Medical Foundation announced it will sell its diagnostic clinical laboratory testing assets to LabCorp. SBMF will reinvest the proceeds from the sale into the organization to further enhance and modernize facilities and procedures, ensure the ability to fund retiree pensions, and focus on its core business of pathology and blood banking services.

Oct. 12, 2018—Walgreens and LabCorp will open at least 600 LabCorp patient service centers at Walgreens stores across the United States over the next four years.

August 2016—LabCorp will acquire Sequenom; New York ends state PT services; St. Jude lands CAP ISO 15189 accreditation; Epigenomics’ DNA test included in CRC guideline; OSU to deploy Inspirata digital pathology solution; Mindray’s clinical chemistry analyzer cleared; Successful Keytruda trial stopped early; Top court clarifies autopsy’s place in Texas law; EUA for Siemens Zika assay

LabCorp recently announced that its biorepository has been accredited by the College of American Pathologists.